BioMarin Pharmaceutical Inc. Profile Avatar - Palmy Investing

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacc…
Biotechnology
US, San Rafael [HQ]
BMRN/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of BMRN's Analysis
CIK: 1048477 CUSIP: 09061G101 ISIN: US09061G1013 LEI: - UEI: -
Secondary Listings